ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kraft, M
Right arrow Articles by Martin, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kraft, M
Right arrow Articles by Martin, R.
Eur Respir J 1995; 8: 1966-1971
Copyright © ERS Journals Ltd 1995

Clinical Trial

Methacholine challenge does not affect bronchoalveolar fluid cell number and many indices of cell function in asthma

M Kraft, CM Bettinger, SE Wenzel, CG Irvin, SJ Ackerman, and RJ Martin

Methacholine (MCh) challenge testing is often incorporated into clinical studies prior to performing bronchoscopy as a measure of bronchial hyperresponsiveness (BHR). However, the effect of methacholine on many aspects of bronchoalveolar lavage (BAL) fluid cell count and function have not been fully evaluated. Ten patients with asthma, maintained on inhaled beta 2-agonists, were studied. Each subject underwent two bronchoscopies in a random order, one preceded by methacholine challenge within 30 min of the BAL. The investigators were blinded to the regimen. Several markers of BAL fluid cell number and function were studied: cell count and differential histamine, eosinophil products, including eosinophil cationic protein and Charcot-Leyden crystal protein, macrophage production of thromboxane B2 and leukotriene B4, neutrophil lysozyme and lactoferrin, and lymphocyte typing and activation markers measured via flow cytometry. No significant differences were noted in any of these markers of cell number or function which could be ascribed to methacholine challenge. Thus, methacholine challenge does not appear to affect these markers of cell number and function. These findings indicate that a methacholine challenge can be used as a measure of bronchial hyperresponsiveness within 30 min prior to bronchoscopy without altering bronchoalveolar lavage fluid characteristics.


This article has been cited by other articles:


Home page
 Eur Respir JHome page
B. Fouty, T. Moss, V. Solodushko, and M. Kraft
Dexamethasone can stimulate G1-S phase transition in human airway fibroblasts in asthma
Eur. Respir. J., June 1, 2006; 27(6): 1160 - 1167.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. Kraft, R. J. Martin, S. C. Lazarus, J. V. Fahy, H. A. Boushey, R. F. Lemanske Jr., and S. J. Szefler
Airway Tissue Mast Cells in Persistent Asthma: Predictor of Treatment Failure When Patients Discontinue Inhaled Corticosteroids
Chest, July 1, 2003; 124(1): 42 - 50.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
R I Ketchell, M D'Amato, M W Jensen, and B J O'Connor
Contrasting effects of allergen challenge on airway responsiveness to cysteinyl leukotriene D4 and methacholine in mild asthma
Thorax, July 1, 2002; 57(7): 575 - 580.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. KRAFT, Q. HAMID, G. P. CHROUSOS, R. J. MARTIN, and D. Y. M. LEUNG
Decreased Steroid Responsiveness at Night in Nocturnal Asthma . Is the Macrophage Responsible?
Am. J. Respir. Crit. Care Med., April 1, 2001; 163(5): 1219 - 1225.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. MULDER, G. M. GAUVREAU, R. M. WATSON, and P. M. O'BYRNE
Effect of Inhaled Leukotriene D4 on Airway Eosinophilia and Airway Hyperresponsiveness in Asthmatic Subjects
Am. J. Respir. Crit. Care Med., May 1, 1999; 159(5): 1562 - 1567.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the European Respiratory Society.